Xiaohong Zhou, M.D., O.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diffusion Magnetic Resonance Imaging | 16 | 2023 | 2737 | 2.950 |
Why?
|
| Echo-Planar Imaging | 6 | 2023 | 659 | 2.200 |
Why?
|
| Calculi | 3 | 2021 | 46 | 1.750 |
Why?
|
| Prostate | 2 | 2023 | 1773 | 0.990 |
Why?
|
| Adenoviridae Infections | 4 | 2016 | 96 | 0.870 |
Why?
|
| Aortic Valve | 2 | 2021 | 1921 | 0.780 |
Why?
|
| Adenoviruses, Human | 5 | 2015 | 257 | 0.770 |
Why?
|
| Keratitis | 5 | 2016 | 268 | 0.750 |
Why?
|
| Phantoms, Imaging | 8 | 2023 | 2480 | 0.740 |
Why?
|
| Leukemic Infiltration | 1 | 2020 | 48 | 0.720 |
Why?
|
| Acceleration | 1 | 2020 | 181 | 0.720 |
Why?
|
| Arthroplasty, Replacement | 1 | 2023 | 339 | 0.690 |
Why?
|
| Artifacts | 4 | 2023 | 1903 | 0.680 |
Why?
|
| Adenovirus Infections, Human | 4 | 2015 | 71 | 0.660 |
Why?
|
| Substantia Nigra | 1 | 2019 | 353 | 0.590 |
Why?
|
| Dextrans | 1 | 2018 | 595 | 0.560 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2023 | 35423 | 0.550 |
Why?
|
| Keratoconjunctivitis | 3 | 2015 | 53 | 0.550 |
Why?
|
| Adenoviridae | 3 | 2016 | 1099 | 0.530 |
Why?
|
| Brain Neoplasms | 3 | 2023 | 8860 | 0.530 |
Why?
|
| Algorithms | 4 | 2023 | 13885 | 0.510 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2018 | 271 | 0.510 |
Why?
|
| Cerium | 2 | 2011 | 7 | 0.500 |
Why?
|
| Image Enhancement | 2 | 2023 | 2921 | 0.500 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2021 | 802 | 0.480 |
Why?
|
| Retinal Ganglion Cells | 3 | 2009 | 771 | 0.460 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2018 | 546 | 0.460 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2023 | 3328 | 0.420 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2023 | 2305 | 0.420 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2016 | 571 | 0.420 |
Why?
|
| Stomach Neoplasms | 1 | 2021 | 1333 | 0.390 |
Why?
|
| Interleukin-18 | 4 | 2009 | 249 | 0.390 |
Why?
|
| Receptors, LDL | 2 | 2011 | 475 | 0.390 |
Why?
|
| Retinal Neovascularization | 2 | 2011 | 244 | 0.380 |
Why?
|
| Bone Marrow | 2 | 2022 | 2944 | 0.370 |
Why?
|
| Image Processing, Computer-Assisted | 7 | 2023 | 8950 | 0.330 |
Why?
|
| Glioma | 2 | 2021 | 3401 | 0.330 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2021 | 2237 | 0.320 |
Why?
|
| Aortic Valve Stenosis | 1 | 2021 | 1965 | 0.320 |
Why?
|
| ROC Curve | 3 | 2021 | 3527 | 0.320 |
Why?
|
| Glaucoma | 2 | 2009 | 1159 | 0.320 |
Why?
|
| Eye Proteins | 3 | 2009 | 646 | 0.320 |
Why?
|
| Serpins | 2 | 2009 | 247 | 0.310 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2022 | 3523 | 0.310 |
Why?
|
| Motion | 3 | 2023 | 798 | 0.300 |
Why?
|
| Brain | 9 | 2023 | 26413 | 0.290 |
Why?
|
| Nerve Growth Factors | 2 | 2009 | 576 | 0.280 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2018 | 1812 | 0.260 |
Why?
|
| Eye Infections, Viral | 2 | 2016 | 57 | 0.250 |
Why?
|
| Parkinson Disease | 1 | 2019 | 2776 | 0.250 |
Why?
|
| Estradiol | 3 | 2007 | 2020 | 0.250 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5221 | 0.250 |
Why?
|
| Retinal Degeneration | 4 | 2011 | 415 | 0.240 |
Why?
|
| Thioredoxins | 4 | 2010 | 213 | 0.240 |
Why?
|
| Photoreceptor Cells, Vertebrate | 3 | 2011 | 204 | 0.230 |
Why?
|
| Adenocarcinoma | 1 | 2021 | 6352 | 0.220 |
Why?
|
| Humans | 41 | 2023 | 744220 | 0.220 |
Why?
|
| Neuroprotective Agents | 2 | 2009 | 941 | 0.220 |
Why?
|
| Mice, Inbred DBA | 3 | 2009 | 642 | 0.210 |
Why?
|
| Cornea | 5 | 2016 | 1524 | 0.200 |
Why?
|
| Research Subjects | 1 | 2023 | 239 | 0.200 |
Why?
|
| Virus Internalization | 2 | 2016 | 501 | 0.190 |
Why?
|
| Viral Tropism | 3 | 2015 | 101 | 0.180 |
Why?
|
| Radio Waves | 1 | 2021 | 251 | 0.180 |
Why?
|
| Permeability | 2 | 2019 | 738 | 0.180 |
Why?
|
| Corneal Stroma | 3 | 2016 | 174 | 0.180 |
Why?
|
| Capsid Proteins | 2 | 2015 | 479 | 0.180 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 1789 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 11 | 2016 | 21824 | 0.170 |
Why?
|
| Mice, Inbred mdx | 1 | 2018 | 90 | 0.170 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 13096 | 0.160 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2005 | 711 | 0.160 |
Why?
|
| Disease Models, Animal | 10 | 2016 | 18027 | 0.160 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2022 | 4044 | 0.160 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2023 | 2208 | 0.160 |
Why?
|
| Oscillometry | 1 | 2018 | 147 | 0.160 |
Why?
|
| Thiocyanates | 2 | 2008 | 70 | 0.160 |
Why?
|
| Normal Distribution | 1 | 2018 | 281 | 0.160 |
Why?
|
| Porosity | 1 | 2018 | 362 | 0.150 |
Why?
|
| Head | 1 | 2023 | 880 | 0.150 |
Why?
|
| Gels | 1 | 2018 | 427 | 0.150 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2016 | 212 | 0.150 |
Why?
|
| Diffusion | 1 | 2018 | 833 | 0.140 |
Why?
|
| src-Family Kinases | 2 | 2016 | 551 | 0.140 |
Why?
|
| Prospective Studies | 4 | 2021 | 53280 | 0.140 |
Why?
|
| Mice | 18 | 2018 | 81178 | 0.130 |
Why?
|
| Clinical Protocols | 1 | 2022 | 1462 | 0.130 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2016 | 262 | 0.130 |
Why?
|
| Male | 14 | 2023 | 350027 | 0.130 |
Why?
|
| Urinary Bladder | 1 | 2021 | 1172 | 0.130 |
Why?
|
| Actigraphy | 1 | 2018 | 488 | 0.120 |
Why?
|
| Retina | 5 | 2010 | 2616 | 0.120 |
Why?
|
| Nerve Fibers | 2 | 2009 | 688 | 0.120 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2016 | 354 | 0.120 |
Why?
|
| Down-Regulation | 3 | 2011 | 3001 | 0.120 |
Why?
|
| Breast | 1 | 2023 | 1969 | 0.120 |
Why?
|
| Atrophy | 1 | 2018 | 1582 | 0.120 |
Why?
|
| Mice, Knockout | 6 | 2016 | 14556 | 0.110 |
Why?
|
| Muscles | 1 | 2018 | 1622 | 0.110 |
Why?
|
| Monte Carlo Method | 1 | 2018 | 1254 | 0.110 |
Why?
|
| Animals | 20 | 2018 | 168788 | 0.110 |
Why?
|
| Tuberous Sclerosis | 1 | 2021 | 1029 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2007 | 1284 | 0.110 |
Why?
|
| Genome, Viral | 2 | 2015 | 667 | 0.110 |
Why?
|
| Caveolin 1 | 1 | 2013 | 264 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2011 | 4752 | 0.100 |
Why?
|
| Adenovirus E3 Proteins | 1 | 2011 | 7 | 0.100 |
Why?
|
| Reaction Time | 1 | 2018 | 2102 | 0.100 |
Why?
|
| Reproducibility of Results | 5 | 2023 | 19907 | 0.100 |
Why?
|
| Apoptosis | 7 | 2011 | 9728 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 3871 | 0.100 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2009 | 528 | 0.090 |
Why?
|
| Recombination, Genetic | 1 | 2015 | 1586 | 0.090 |
Why?
|
| Intraocular Pressure | 2 | 2007 | 1274 | 0.090 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2007 | 300 | 0.090 |
Why?
|
| Intravitreal Injections | 1 | 2011 | 345 | 0.090 |
Why?
|
| Female | 15 | 2023 | 380197 | 0.090 |
Why?
|
| Neoplasms | 1 | 2018 | 21672 | 0.090 |
Why?
|
| NF-kappa B | 3 | 2007 | 2501 | 0.080 |
Why?
|
| Thioredoxin Reductase 1 | 1 | 2008 | 31 | 0.080 |
Why?
|
| Brain Diseases | 1 | 2018 | 1564 | 0.080 |
Why?
|
| Flow Cytometry | 4 | 2015 | 5974 | 0.080 |
Why?
|
| DNA, Viral | 2 | 2013 | 2226 | 0.080 |
Why?
|
| Epitopes | 1 | 2015 | 2571 | 0.080 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2007 | 643 | 0.080 |
Why?
|
| Echocardiography | 1 | 2021 | 5103 | 0.080 |
Why?
|
| Caspase 3 | 2 | 2008 | 759 | 0.080 |
Why?
|
| Cell Count | 2 | 2010 | 1854 | 0.080 |
Why?
|
| Corneal Diseases | 1 | 2015 | 636 | 0.080 |
Why?
|
| Patient Compliance | 1 | 2018 | 2684 | 0.080 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 4841 | 0.080 |
Why?
|
| Cognition | 2 | 2023 | 6765 | 0.080 |
Why?
|
| Digoxigenin | 1 | 2007 | 26 | 0.080 |
Why?
|
| Capsid | 1 | 2010 | 436 | 0.080 |
Why?
|
| Blotting, Western | 4 | 2011 | 5180 | 0.080 |
Why?
|
| Eye Diseases | 1 | 2013 | 668 | 0.070 |
Why?
|
| Brain Mapping | 1 | 2023 | 6671 | 0.070 |
Why?
|
| Oncogene Protein v-akt | 1 | 2007 | 135 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2023 | 5529 | 0.070 |
Why?
|
| Estrogen Antagonists | 1 | 2007 | 151 | 0.070 |
Why?
|
| Eye | 1 | 2011 | 729 | 0.070 |
Why?
|
| Reactive Oxygen Species | 2 | 2011 | 2078 | 0.070 |
Why?
|
| Metal Nanoparticles | 1 | 2011 | 405 | 0.070 |
Why?
|
| Drug Implants | 1 | 2007 | 243 | 0.070 |
Why?
|
| Adult | 5 | 2021 | 214035 | 0.070 |
Why?
|
| Photoreceptor Cells | 1 | 2007 | 244 | 0.070 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2010 | 770 | 0.070 |
Why?
|
| Survival Rate | 1 | 2020 | 12781 | 0.070 |
Why?
|
| Optic Nerve | 1 | 2009 | 556 | 0.070 |
Why?
|
| Electroretinography | 4 | 2011 | 509 | 0.070 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2011 | 1372 | 0.070 |
Why?
|
| Exercise | 1 | 2022 | 5615 | 0.060 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2005 | 149 | 0.060 |
Why?
|
| Tamoxifen | 2 | 2007 | 981 | 0.060 |
Why?
|
| Dendritic Cells | 1 | 2016 | 2725 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2021 | 21752 | 0.060 |
Why?
|
| Ciliary Body | 1 | 2005 | 173 | 0.060 |
Why?
|
| Oligopeptides | 1 | 2010 | 1178 | 0.060 |
Why?
|
| Ovariectomy | 1 | 2007 | 661 | 0.060 |
Why?
|
| Early Detection of Cancer | 1 | 2018 | 3086 | 0.060 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 514 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 2 | 2013 | 4803 | 0.060 |
Why?
|
| Iris | 1 | 2005 | 239 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 15070 | 0.060 |
Why?
|
| Cell Survival | 2 | 2011 | 5881 | 0.060 |
Why?
|
| Middle Aged | 5 | 2022 | 213367 | 0.060 |
Why?
|
| Models, Statistical | 1 | 2018 | 5102 | 0.060 |
Why?
|
| Macular Degeneration | 1 | 2011 | 981 | 0.060 |
Why?
|
| Cell Death | 1 | 2009 | 1708 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2015 | 2958 | 0.060 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2005 | 472 | 0.060 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2005 | 906 | 0.060 |
Why?
|
| Cochlea | 1 | 2008 | 829 | 0.050 |
Why?
|
| Light | 2 | 2005 | 1374 | 0.050 |
Why?
|
| Lectins, C-Type | 1 | 2005 | 588 | 0.050 |
Why?
|
| Diabetic Retinopathy | 1 | 2011 | 1210 | 0.050 |
Why?
|
| Immunohistochemistry | 4 | 2010 | 11368 | 0.050 |
Why?
|
| Macrophages | 1 | 2016 | 5657 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2023 | 3760 | 0.050 |
Why?
|
| Aged | 4 | 2023 | 163253 | 0.050 |
Why?
|
| Phosphorylation | 3 | 2007 | 8437 | 0.050 |
Why?
|
| Pandemics | 1 | 2021 | 8387 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2007 | 3701 | 0.050 |
Why?
|
| Stroke | 1 | 2023 | 9981 | 0.050 |
Why?
|
| Transfection | 1 | 2009 | 5892 | 0.050 |
Why?
|
| Proteins | 4 | 2011 | 6101 | 0.050 |
Why?
|
| Visual Acuity | 1 | 2009 | 2530 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2011 | 1905 | 0.040 |
Why?
|
| Prognosis | 1 | 2020 | 29050 | 0.040 |
Why?
|
| Perfusion | 1 | 2023 | 1359 | 0.040 |
Why?
|
| Lipoproteins | 1 | 2004 | 878 | 0.040 |
Why?
|
| Mutation | 1 | 2023 | 29784 | 0.040 |
Why?
|
| Sulfoxides | 2 | 2008 | 48 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2021 | 11074 | 0.040 |
Why?
|
| Isothiocyanates | 2 | 2008 | 51 | 0.040 |
Why?
|
| Signal Transduction | 4 | 2011 | 23404 | 0.040 |
Why?
|
| Antioxidants | 1 | 2006 | 1663 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2011 | 2915 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 25043 | 0.040 |
Why?
|
| Young Adult | 2 | 2021 | 56436 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2007 | 4217 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 4419 | 0.040 |
Why?
|
| Gene Expression | 2 | 2010 | 7799 | 0.040 |
Why?
|
| Microscopy, Confocal | 2 | 2015 | 1971 | 0.040 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2016 | 87 | 0.030 |
Why?
|
| Chemokine CXCL1 | 1 | 2016 | 101 | 0.030 |
Why?
|
| Adolescent | 2 | 2021 | 85759 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 20817 | 0.030 |
Why?
|
| Cell Line | 3 | 2015 | 15999 | 0.030 |
Why?
|
| Tetrazolium Salts | 2 | 2006 | 96 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2008 | 625 | 0.030 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2008 | 377 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2023 | 2309 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2006 | 3085 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 11732 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2005 | 4026 | 0.030 |
Why?
|
| Vision, Ocular | 2 | 2010 | 464 | 0.030 |
Why?
|
| Mice, Mutant Strains | 2 | 2008 | 1866 | 0.030 |
Why?
|
| Basement Membrane | 1 | 2015 | 356 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1782 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2004 | 2938 | 0.030 |
Why?
|
| Pain, Postoperative | 1 | 2023 | 1640 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2015 | 713 | 0.030 |
Why?
|
| Models, Immunological | 1 | 2015 | 527 | 0.030 |
Why?
|
| Acute Disease | 1 | 2022 | 7148 | 0.020 |
Why?
|
| Hydrogen Peroxide | 2 | 2006 | 731 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 4553 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 9735 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 4465 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2007 | 12075 | 0.020 |
Why?
|
| Aging | 2 | 2008 | 8661 | 0.020 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2010 | 65 | 0.020 |
Why?
|
| Proteomics | 1 | 2023 | 3637 | 0.020 |
Why?
|
| Systems Biology | 1 | 2013 | 469 | 0.020 |
Why?
|
| Insulin | 1 | 2004 | 6583 | 0.020 |
Why?
|
| Genes, Viral | 1 | 2010 | 718 | 0.020 |
Why?
|
| Age Factors | 2 | 2021 | 18367 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2022 | 8321 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2013 | 1526 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2013 | 2256 | 0.020 |
Why?
|
| Phylogeny | 1 | 2015 | 2803 | 0.020 |
Why?
|
| Thiazoles | 2 | 2006 | 1484 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2005 | 10182 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2010 | 617 | 0.020 |
Why?
|
| Sleep | 1 | 2023 | 4623 | 0.020 |
Why?
|
| Thioredoxin-Disulfide Reductase | 1 | 2007 | 45 | 0.020 |
Why?
|
| Anticarcinogenic Agents | 1 | 2008 | 253 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2007 | 2503 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2011 | 2839 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2011 | 907 | 0.020 |
Why?
|
| Nerve Net | 1 | 2018 | 2175 | 0.020 |
Why?
|
| Arrestin | 1 | 2005 | 30 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2010 | 604 | 0.020 |
Why?
|
| Transducin | 1 | 2005 | 46 | 0.020 |
Why?
|
| Viral Proteins | 1 | 2013 | 1900 | 0.020 |
Why?
|
| Oxidants | 1 | 2006 | 164 | 0.020 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2006 | 220 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2005 | 180 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 9960 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2013 | 4012 | 0.020 |
Why?
|
| Enzyme Inhibitors | 2 | 2007 | 3800 | 0.020 |
Why?
|
| Recoverin | 1 | 2004 | 13 | 0.020 |
Why?
|
| Hippocalcin | 1 | 2004 | 8 | 0.020 |
Why?
|
| Cholesterol | 1 | 2013 | 2911 | 0.020 |
Why?
|
| Cell Separation | 1 | 2010 | 1751 | 0.010 |
Why?
|
| Nerve Degeneration | 1 | 2008 | 748 | 0.010 |
Why?
|
| Flavonoids | 1 | 2007 | 443 | 0.010 |
Why?
|
| Chromones | 1 | 2004 | 154 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2004 | 242 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 1155 | 0.010 |
Why?
|
| Virus Replication | 1 | 2011 | 2534 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 1990 | 0.010 |
Why?
|
| src Homology Domains | 1 | 2004 | 364 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2013 | 4156 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2013 | 5458 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2011 | 2902 | 0.010 |
Why?
|
| Caspases | 1 | 2005 | 928 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2011 | 6367 | 0.010 |
Why?
|
| Disease Progression | 1 | 2018 | 13280 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 595 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2007 | 2726 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2004 | 566 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 1801 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2005 | 2505 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 13817 | 0.010 |
Why?
|
| Morpholines | 1 | 2004 | 573 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 18116 | 0.010 |
Why?
|
| Receptor, Insulin | 1 | 2004 | 846 | 0.010 |
Why?
|
| Protein Transport | 1 | 2005 | 1989 | 0.010 |
Why?
|
| Progesterone | 1 | 2004 | 776 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 2006 | 19227 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 1080 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3921 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 3506 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2022 | 63119 | 0.010 |
Why?
|
| Child | 1 | 2021 | 77679 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2013 | 25618 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 77426 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 8302 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2007 | 13036 | 0.010 |
Why?
|
| Protein Binding | 1 | 2004 | 9392 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 10949 | 0.010 |
Why?
|
| Models, Biological | 1 | 2007 | 9582 | 0.010 |
Why?
|
| Rats | 1 | 2004 | 24273 | 0.000 |
Why?
|
| Neurons | 1 | 2004 | 9335 | 0.000 |
Why?
|